# Study to Evaluate the Efficacy and Safety of Tegoprazan in ERD Patients With Nighttime Heartburn and Sleep Disturbance

> **NCT04309916** · PHASE4 · COMPLETED · sponsor: **HK inno.N Corporation** · enrollment: 46 (actual)

## Conditions studied

- Erosive Reflux Disease

## Interventions

- **DRUG:** Tegoprazan
- **DRUG:** Esomeprazole

## Key facts

- **NCT ID:** NCT04309916
- **Lead sponsor:** HK inno.N Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-22
- **Primary completion:** 2021-11-30
- **Final completion:** 2021-11-30
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2022-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04309916

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04309916, "Study to Evaluate the Efficacy and Safety of Tegoprazan in ERD Patients With Nighttime Heartburn and Sleep Disturbance". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04309916. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*